Thyroid diseases and cerebrovascular disease

Acute cerebral ischemia has been described in different diseases of the thyroid gland, and not only as a result of thyrotoxic atrial fibrillation and cardioembolic stroke. The purpose of this review is to summarize the studies on the relationship between thyroid diseases and cerebrovascular diseases...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Stroke (1970) 2005-10, Vol.36 (10), p.2302-2310
Hauptverfasser:	SQUIZZATO, A, GERDES, V. E. A, BRANDJES, D. P. M, BÜLLER, H. R, STAM, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiphospholipid Syndrome - complications Atrial Fibrillation Biological and medical sciences Blood Pressure Brain Ischemia - complications Cardiology. Vascular system Case-Control Studies Cerebrovascular Disorders - complications Embolism - complications Endocardial and cardiac valvular diseases Errors of metabolism Female Giant Cell Arteritis - complications Heart Humans Hyperthyroidism - complications Hypothyroidism - complications Lipids (lysosomal enzyme disorders, storage diseases) Male Medical sciences Metabolic diseases Moyamoya Disease - complications Neurology Risk Risk Factors Stroke Thrombophilia - complications Thyroid Diseases - complications Vascular diseases and vascular malformations of the nervous system Vasculitis, Central Nervous System - complications Venous Thrombosis - complications
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Acute cerebral ischemia has been described in different diseases of the thyroid gland, and not only as a result of thyrotoxic atrial fibrillation and cardioembolic stroke. The purpose of this review is to summarize the studies on the relationship between thyroid diseases and cerebrovascular diseases, discussing the main findings for overt hyperthyroidism and hypothyroidism, as well as for subclinical thyroid dysfunction. In overt hyperthyroidism, cardioembolic stroke is clearly associated to thyrotoxic atrial fibrillation, and in subclinical hyperthyroidism with serum thyroid-stimulating hormone levels
ISSN:	0039-2499 1524-4628
DOI:	10.1161/01.str.0000181772.78492.07